JJIJ
FUSN

Johnson & Johnson Innovation - JJDC’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$29.7M Hold
3,670,516
– – 3.03% 7
2021
Q1 		$39.3M Hold
3,670,516
– – 5.1% 7
2020
Q4 		$43.1M Hold
3,670,516
– – 5.56% 6
2020
Q3 		$44.1M Hold
3,670,516
– – 8.88% 5
2020
Q2 		$64.1M Buy
+3,670,516
New +$63.9M 12.6% 4

Other funds holding FUSN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's FUSN Position: Q2 2021 in Review

Johnson & Johnson Innovation - JJDC held its Fusion Pharmaceuticals Inc. Common Shares (FUSN) position steady in Q2 2021 at 3,670,516 shares worth $29.7M. The position accounts for 3.03% of the portfolio, ranked #7.

Johnson & Johnson Innovation - JJDC first reported a position in FUSN in Q2 2020 and has held it in 5 quarters since. The position peaked at $64.1M in Q2 2020. 39 funds tracked by Wall St. Rank hold FUSN as of Q2 2021.

  • Johnson & Johnson Innovation - JJDC held 3,670,516 shares of Fusion Pharmaceuticals Inc. Common Shares worth $29.7M as of Q2 2021.
  • Johnson & Johnson Innovation - JJDC left its Fusion Pharmaceuticals Inc. Common Shares share count unchanged in Q2 2021.
  • Fusion Pharmaceuticals Inc. Common Shares made up 3.03% of Johnson & Johnson Innovation - JJDC's portfolio in Q2 2021, its #7 holding.
  • Johnson & Johnson Innovation - JJDC first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and has held it in 5 quarters since.
  • Johnson & Johnson Innovation - JJDC's Fusion Pharmaceuticals Inc. Common Shares position peaked at $64.1M in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2021.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q2 2021, filed 3 Aug 2021.